The study shows TPP-LIP@PCSK9 simultaneously downregulates mitochondrial damage markers PINK1/Parkin while activating the Nrf2/UCP2 antioxidant pathway. The mechanistic connection between these opposing mitochondrial quality control processes remains unclear, which is important for understanding mitochondrial dysfunction in cerebrovascular disease. Gap type: unexplained_observation Source paper: A mechanistic study of mitochondria-targeted PCSK9 liposomes attenuate oxidative damage in carotid artery plaques. (2026, Journal of liposome research, PMID:41906524)
Landscape Summary: What is the relationship between PINK1/Parkin downregulation and Nrf2/UCP2 pathway activation? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What is the relationship between PINK1/Parkin downregulation and Nrf2/UCP2 pathway activation? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: